FDCP
BMY icon

Foster Dykema Cabot & Partners’s Bristol-Myers Squibb BMY Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.8K Hold
1,348
– – 0.01% 163
2025
Q4 		$72.7K Sell
1,348
-549
-29% -$26.4K ﹤0.01% 176
2025
Q3 		$84.4K Buy
1,897
+679
+56% +$31.7K 0.01% 184
2025
Q2 		$56.5K Hold
1,218
– – ﹤0.01% 186
2025
Q1 		$74.3K Hold
1,218
– – 0.01% 172
2024
Q4 		$68.9K Hold
1,218
– – 0.01% 187
2024
Q3 		$63K Hold
1,218
– – 0.01% 199
2024
Q2 		$50.6K Hold
1,218
– – ﹤0.01% 176
2024
Q1 		$66.1K Hold
1,218
– – 0.01% 166
2023
Q4 		$62.5K Buy
+1,218
New +$63.9K 0.01% 144

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Foster Dykema Cabot & Partners's BMY Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 1,348 shares worth $81.8K. The position accounts for 0.01% of the portfolio, ranked #163.

Foster Dykema Cabot & Partners first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $84.4K in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Foster Dykema Cabot & Partners held 1,348 shares of Bristol-Myers Squibb worth $81.8K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #163 holding.
  • Foster Dykema Cabot & Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Foster Dykema Cabot & Partners's Bristol-Myers Squibb position peaked at $84.4K in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.